HealthEquity, Inc.
News
EVP At HealthEquity Sells $947K Of Stock
Benzinga Making a noteworthy insider sell on September 10, Elimelech Rosner, EVP at HealthEquity HQY, is reported in the latest SEC filing. What Happened: Rosner's decision to sell 12,296 shares of HealthEquity was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday.\n more…
Why HealthEquity (HQY) is a Top Momentum Stock for the Long-Term
Zacks Investment Research For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.The popular research...\n more…
HQY vs. MEDP: Which Stock Is the Better Value Option?
Zacks Investment Research Investors interested in stocks from the Medical Services sector have probably already heard of HealthEquity (HQY) and Medpace (MEDP). But which of these two companies is the best option for those...\n more…
Wall Street Analysts Believe HealthEquity Could Rally 36.59%: Here's is How to Trade
Benzinga HealthEquity (NASDAQ: HQY) closed the last trading session at $76.24, gaining 7.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $104.14 indicates a 36.6% upside potential.\n more…